Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

455 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Paulke-Korinek M, et al. Among authors: kundi m. Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434. Pediatr Infect Dis J. 2010. PMID: 19935446
Respiratory tract infections due to different rhinovirus serotypes and the influence of maternal antibodies on the clinical expression of the disease in infants.
Kellner G, Popow-Kraupp T, Binder C, Goedl I, Kundi M, Kunz C. Kellner G, et al. Among authors: kundi m. J Med Virol. 1991 Dec;35(4):267-72. doi: 10.1002/jmv.1890350412. J Med Virol. 1991. PMID: 1666405
Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy.
Hirschl AM, Brandstätter G, Dragosics B, Hentschel E, Kundi M, Rotter ML, Schütze K, Taufer M. Hirschl AM, et al. Among authors: kundi m. J Infect Dis. 1993 Sep;168(3):763-6. doi: 10.1093/infdis/168.3.763. J Infect Dis. 1993. PMID: 8354918 Clinical Trial.
Inactivated hepatitis A vaccine: long-term antibody persistence.
Wiedermann G, Kundi M, Ambrosch F, Safary A, D'Hondt E, Delem A. Wiedermann G, et al. Among authors: kundi m. Vaccine. 1997 Apr-May;15(6-7):612-5. doi: 10.1016/s0264-410x(96)00242-3. Vaccine. 1997. PMID: 9178459 Clinical Trial.
Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule).
Wiedermann G, Kundi M, Ambrosch F. Wiedermann G, et al. Among authors: kundi m. Acta Trop. 1998 May;69(2):121-5. doi: 10.1016/s0001-706x(97)00120-4. Acta Trop. 1998. PMID: 9588232
Adverse events after oral vaccination against cholera with CVD103-HgR.
Wiedermann G, Kollaritsch H, Jeschko E, Kundi M, Herzog C, Wegmüller B. Wiedermann G, et al. Among authors: kundi m. Wien Klin Wochenschr. 1998 May 22;110(10):376-8. Wien Klin Wochenschr. 1998. PMID: 9654693
Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report).
Wiedermann G, Kollaritsch H, Kundi M, Svennerholm AM, Bjare U. Wiedermann G, et al. Among authors: kundi m. J Travel Med. 2000 Jan;7(1):27-9. doi: 10.2310/7060.2000.00007. J Travel Med. 2000. PMID: 10689236 Clinical Trial.
Different HBs antibody versus lymphoproliferative responses after application of a monovalent (hepatitis B) or combined (hepatitis A + hepatitis B) vaccine.
Wiedermann U, Kundi M, Vollmann U, Kollaritsch H, Ebner C, Wiedermann G. Wiedermann U, et al. Among authors: kundi m. Int Arch Allergy Immunol. 2000 Dec;123(4):349-53. doi: 10.1159/000053648. Int Arch Allergy Immunol. 2000. PMID: 11146393 Clinical Trial.
Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience.
Rendi-Wagner P, Kundi M, Stemberger H, Wiedermann G, Holzmann H, Hofer M, Wiesinger K, Kollaritsch H. Rendi-Wagner P, et al. Among authors: kundi m. Vaccine. 2001 Feb 28;19(15-16):2055-60. doi: 10.1016/s0264-410x(00)00410-2. Vaccine. 2001. PMID: 11228377 Clinical Trial.
Screening for possible failure of herpes simplex virus PCR in cerebrospinal fluid for the diagnosis of herpes simplex encephalitis.
Puchhammer-Stöckl E, Presterl E, Croÿ C, Aberle S, Popow-Kraupp T, Kundi M, Hofmann H, Wenninger U, Gödl I. Puchhammer-Stöckl E, et al. Among authors: kundi m. J Med Virol. 2001 Aug;64(4):531-6. doi: 10.1002/jmv.1082. J Med Virol. 2001. PMID: 11468740
455 results
Jump to page